From News Desk

Tata Elxsi, a provider of design and technology services, has announced the launch of AnaTel, an AI-native software development platform for healthcare and medical technology companies, co-developed with OpenAna, a provider of autonomous AI engineering platforms. AnaTel makes its debut at DeviceTalks Boston 2026, where Tata Elxsi is presenting its latest advances in AI-powered MedTech engineering and compliance.

AnaTel embeds autonomous AI agents directly into the engineering workflow. It operates across the full AI-driven software delivery lifecycle, from requirements and architecture through deployment, verification and validation and continuous optimisation. Operating as a configurable AI software team, AnaTel generates code, documentation, test cases and regulatory artifacts, drawing on a dedicated Healthcare and Life Sciences expert agent fine-tuned for medtech regulatory and engineering contexts. Human engineers and regulatory experts remain in control at every critical review and decision point. The platform supports E-STAR-aligned submission preparation, requirements traceability matrices, verification and validation evidence and audit-trail documentation as part of day-to-day engineering. It is expected to reduce SaMD development and change assessment timelines from eight weeks to 72 hours, with productivity improvements of up to 60%.

Tata Elxsi brings design-led and AI-first engineering, deep domain expertise and access to global healthcare and medtech enterprises. OpenAna brings platform and technology innovation.

Sreevatsa Sahasranaman, Senior VP and Head, Healthcare and Life Sciences, Tata Elxsi said, “AnaTel accelerates regulatory-ready software engineering by bringing autonomous AI agents directly into the development workflows that shape compliance and submission readiness, while keeping our customers’ engineering and regulatory experts firmly in control.”

Rajiv Sondhi, CEO, OpenAna said, “Our mission at OpenAna is to provide autonomous AI agents that work as reliable co-engineers alongside human teams. Partnering with Tata Elxsi on AnaTel brings this capability into one of the most demanding domains, regulated healthcare and medtech, where lifecycle traceability, safety and compliance are as important as speed. Tata Elxsi’s domain expertise and AI-first engineering ensure the platform is genuinely contextualized for the regulatory realities medtech teams face every day.”

Muthusamy Selvaraj, VP, Innovation and Partnerships, Healthcare and Life Sciences, Tata Elxsi sad, “The question that led to AnaTel™ was a simple one: what could the world’s best autonomous engineering capability become if it truly understood healthcare? That question is how this partnership with OpenAna was born, and it is how STEP.UP works in practice. We are accountable for the outcome. That is what makes this model different.”